Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

325
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
325

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

First quinquennium completed: highlights from <i>EHJ Open</i> 2025.

European heart journal open·2026
Same author

Marshall-plan ablation strategy for recurrent persistent atrial fibrillation in patients with durably isolated pulmonary veins.

Heart rhythm·2026
Same author

Digital Cognitive Behavioral Therapy for Cardiac Anxiety After Myocardial Infarction: Effects on Disease-Specific Health Status-Detailed Methods and Protocol.

JACC. Advances·2026
Same author

Digital Cognitive Behavioral Therapy for Cardiac Anxiety After Myocardial Infarction: Effects on Disease-Specific Health Status-Randomized Trial Results.

Journal of the American College of Cardiology·2026
Same author

'Ablate and pace' reduces mortality in heart failure patients with atrial fibrillation: an updated meta-analysis.

European heart journal open·2026
Same author

Protein biomarkers associated with left bundle branch block in patients with heart failure and reduced ejection fraction.

ESC heart failure·2026

相关实验视频

Updated: May 5, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K

[静脉切除 - - 一个技术上复杂的程序]

Finn Åkerström1, Nikola Drca2, Jonas Schwieler3

  • 1överläkare, ME kardiologi, , ME kardiologi, Hjärt-kärlcentrum.

Lakartidningen
|June 4, 2024
PubMed
概括

在结构性心脏病患者中,心室动脉冲动 (VT) 移除是有效但复杂的. 瑞典的数据显示,18%的VT复发和除后很少出现重大不良事件,这表明更早的转诊可能会改善结果.

更多相关视频

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.6K
Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

14.7K

相关实验视频

Last Updated: May 5, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K
Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.6K
Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

14.7K

科学领域:

  • 心脏病学 心脏病学
  • 电子生理学 电子生理学
  • 医疗器械技术 医疗器械技术

背景情况:

  • 结构性心脏病中的心室低心率 (VT) 是危及生命的,通常需要植入式心脏转换器-除器 (ICD).
  • 导管切除提供了一种治疗策略,以减轻静脉瘤复发和减少ICD冲击.
  • 有限的数据存在VT废除的结果和风险,特别是在瑞典.

研究的目的:

  • 分析结构性心脏病患者的静脉瘤切除结果和手术风险.
  • 贡献瑞典关于静脉瘤切除疗效和安全的第一个数据.
  • 评估手术时间对患者结果的影响.

主要方法:

  • 在对来自单一中心的静脉瘤切除数据进行分析的同时,还进行了文献综述.
  • 60名患有结构性心脏病的患者在2021年至2022年期间接受了68次静脉切除术.
  • 收集和分析了随访数据,包括静脉瘤复发,不良事件和死亡率.

主要成果:

  • 在平均20个月的随访后,18%的患者出现了静脉瘤复发.
  • 发生了两个主要不良事件 (中风,完全心房阻塞).
  • 记录了7例非心律失常相关的死亡;68%的手术是亚急性,与更高的风险相关.

结论:

  • 静脉管切除是可行的,并且与瑞典结构性心脏病患者的可控风险有关.
  • 在晚期疾病进展之前,早期转诊进行静脉管切除可能会改善患者的治疗结果.
  • 进一步的研究是有必要的,以优化患者选择和程序策略.